Home
Shares
News Centre
F&O
Mutual Funds
IPO
Portfolio
Commodity
Loans
Financial Planning
Insurance
About Us
Markets
Companies
Research
Industries
E-Mail Page
Get NAV
Snapshot
Portfolio
Dividends
News
Interviews
Charts
Get Quote
Snapshot
Charts
Financials
Research
News
Wealth Tracker
Tax Corner
NRI Centre
Chat Masala
Feedback
my
Last 5 Scrips
Company
BSE Price(Rs)
% Chg
Yes Bank
24.08
42.49
Tata Stl
136.10
30.24
Ong Corp
255.50
95.26
I T C Lt
439.00
28.72
Ntpc Ltd
318.20
88.67
Clear All
Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Zydus Lifesciences Limited
Zydus Lifesciences Limited
Sector:Pharmaceuticals
Pharmaceuticals - Formulations
BSE:
532321
NSE:
ZYDUSLIFE
Bloomberg:
CDH@IN
Reuters:
CADI.BO
Market Lot: 1
Face Value: 1
ISIN Demat: INE010B01027
Quotes
Snapshot
Charts
Financials
Research
Recent News
Peer Group
AGM/AM
MF Holding
Discussion Forum
BSE/NSE Notices
BSE/NSE Deals
Corporate News
10-Mar-2022
Zydus gets final nod from USFDA for Nitroglycerin Sublingual Tablets
IRIS
09-Mar-2022
Zydus Lifesciences arm executes asset purchase agreement with BridgeBio
IRIS
23-Feb-2022
Cadila Healthcare gets final nod from USFDA for Dapagliflozin Tablets
IRIS
02-Feb-2022
Zydus supplies first consignment of COVID-19 vaccine ZyCoV-D
IRIS
13-Dec-2021
Zydus gets approval for Phase II Clinical study in patients with CAPS in Australia
IRIS
Home
|
Shares
|
F&O
|
Mutual Funds
|
Loans
|
Insurance
|
News Centre
Wealth Tracker
|
Tax Corner
|
NRI Centre
|
Search in myiris
|
Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer
Recent News